{"id":13018,"date":"2010-12-22T06:34:14","date_gmt":"2010-12-22T11:34:14","guid":{"rendered":"http:\/\/asweetlife.org\/?p=13018"},"modified":"2015-12-28T07:29:31","modified_gmt":"2015-12-28T12:29:31","slug":"teva-to-market-a-generic-version-of-actos-in-2012","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=13018","title":{"rendered":"Teva To Market a Generic Version of ACTOS in 2012"},"content":{"rendered":"

\"\"<\/a>Takeda Pharmaceutical Company Limited has granted Teva Pharmaceutical Industries Ltd. a license to market a generic version of ACTOS\u00ae in the U.S. beginning on August 17, 2012, and a generic version of ACTOplus met\u00ae beginning December 14, 2012. The license was granted following an agreement to settle patent litigation related to Teva’s generic versions of Takeda’s ACTOS\u00ae (pioglitazone HCl) and ACTOplus met\u00ae (pioglitazone HCl and metformin HCl) in the United States.<\/p>\n

Source: www.tevapharm.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Takeda Pharmaceutical Company Limited has granted Teva Pharmaceutical Industries Ltd. a license to market a generic version of ACTOS\u00ae in the U.S. beginning on August 17, 2012, and a generic version of ACTOplus met\u00ae beginning December 14, 2012. The license was granted following an agreement to settle patent litigation related to Teva’s generic versions of Takeda’s ACTOS\u00ae (pioglitazone HCl) and ACTOplus met\u00ae (pioglitazone HCl and metformin HCl) in the United States…<\/p>\n","protected":false},"author":131,"featured_media":13019,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1442],"tags":[276,1017],"yoast_head":"\nDiabetes Drug Actos: Teva to Market Generic Version by 2012<\/title>\n<meta name=\"description\" content=\"Takeda Pharmaceutical has granted Teva Pharmaceutical a license to market a generic version of ACTOS in the U.S. beginning on August 17, 2012, and a generic version of ACTOplus met beginning December 14, 2012.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=13018\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=13018\",\"url\":\"https:\/\/asweetlife.org\/?p=13018\",\"name\":\"Diabetes Drug Actos: Teva to Market Generic Version by 2012\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=13018#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=13018#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/12\/Logo_Teva_home.jpg\",\"datePublished\":\"2010-12-22T11:34:14+00:00\",\"dateModified\":\"2015-12-28T12:29:31+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"Takeda Pharmaceutical has granted Teva Pharmaceutical a license to market a generic version of ACTOS in the U.S. beginning on August 17, 2012, and a generic version of ACTOplus met beginning December 14, 2012.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=13018#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=13018\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=13018#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/12\/Logo_Teva_home.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/12\/Logo_Teva_home.jpg\",\"width\":185,\"height\":178,\"caption\":\"TEVA\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=13018#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teva To Market a Generic Version of ACTOS in 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Diabetes Drug Actos: Teva to Market Generic Version by 2012","description":"Takeda Pharmaceutical has granted Teva Pharmaceutical a license to market a generic version of ACTOS in the U.S. beginning on August 17, 2012, and a generic version of ACTOplus met beginning December 14, 2012.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=13018","twitter_misc":{"Written by":"ASweetLife Team"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=13018","url":"https:\/\/asweetlife.org\/?p=13018","name":"Diabetes Drug Actos: Teva to Market Generic Version by 2012","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=13018#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=13018#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/12\/Logo_Teva_home.jpg","datePublished":"2010-12-22T11:34:14+00:00","dateModified":"2015-12-28T12:29:31+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"Takeda Pharmaceutical has granted Teva Pharmaceutical a license to market a generic version of ACTOS in the U.S. beginning on August 17, 2012, and a generic version of ACTOplus met beginning December 14, 2012.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=13018#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=13018"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=13018#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/12\/Logo_Teva_home.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/12\/Logo_Teva_home.jpg","width":185,"height":178,"caption":"TEVA"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=13018#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Teva To Market a Generic Version of ACTOS in 2012"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/13018"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13018"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/13018\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/13019"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}